pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 63 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
(minoxidil + finasteride + latanoprost)
Androgenic Alopecia
Triple Hair Inc
0 catalysts
Phase 2
(plerixafor + tacrolimus)
Wounds
MedRegen LLC
0 catalysts
Phase 2
ABS-201
Androgenic Alopecia
Almirall SA
0 catalysts
Phase 2
AGLE-102
Burns
Aegle Therapeutics Corp
← prev
page 1 of 3
next →
131
Pain89
Neurology1
0 catalysts
Phase 2
ALY-101
Alopecia Areata
Alys Pharmaceuticals Inc
0 catalysts
Phase 2
AMTX-100
Atopic Dermatitis (Atopic Eczema)
Amytrx Therapeutics Inc
0 catalysts
Phase 2
ATR-04
Skin Rash
$AZTRAzitra, Inc.
0 catalysts
Phase 2
BCX-17725
Netherton Syndrome (Bamboo Hair)
$BCRXBIOCRYST PHARMACEUTICALS INC
0 catalysts
Phase 2
BLU-808
Chronic Inducible Urticaria
Blueprint Medicines Corp
0 catalysts
Phase 2
CBL-514
Adiposis Dolorosa (Dercum's Disease or Anders Disease)
Caliway Biopharmaceutics Co Ltd
0 catalysts
Phase 2
CX-001
Nevus
Calissa Therapeutics
0 catalysts
Phase 2
DLQ-01
Androgenic Alopecia
Dermaliq Therapeutics Inc
0 catalysts
Phase 2
ELU-42
Diabetic Foot Ulcers
Eluciderm Inc
0 catalysts
Phase 2
EVO-756
Chronic Inducible Urticaria
$EVMNEvommune, Inc.
0 catalysts
Phase 2
EXG-34217
Dyskeratosis Congenita (Zinsser-Cole-Engman Syndrome)
Elixirgen Therapeutics Inc
0 catalysts
Phase 2
FB-825
Atopic Dermatitis (Atopic Eczema)
Oneness Biotech Co Ltd
0 catalysts
Phase 2
IMB-101
Hidradenitis Suppurativa
Navigator Medicines Inc
0 catalysts
Phase 2
IMG-007
Atopic Dermatitis (Atopic Eczema)
$IMAImageneBio, Inc.
0 catalysts
Phase 2
ISN-001
Diabetic Foot Ulcers
Anterogen Co Ltd
0 catalysts
Phase 2
KT-621
Eosinophilic Asthma
$KYMRKymera Therapeutics, Inc.
0 catalysts
Phase 2
LUT-014
Acne And Related Disorders
Lutris Pharma
0 catalysts
Phase 2
MC-232
Hidradenitis Suppurativa
MC2 Therapeutics AS
0 catalysts
Phase 2
MDI-1228
Diabetic Foot Ulcers
Henan Maiyingnuo Pharmaceutical Technology Co Ltd
0 catalysts
Phase 2
MTX-001
Venous Leg Ulcers (Crural Ulcer)
Merakris Therapeutics Inc
0 catalysts
Phase 2
NanoDOX
Wounds
Resilience Government Services Inc
0 catalysts
Phase 2
Nu-3
Diabetic Foot Ulcers
Lakewood-Amedex Inc
0 catalysts
Phase 2
NuGel
Atopic Dermatitis (Atopic Eczema)
Hudson Therapeutics Inc
0 catalysts
Phase 2
OLX-101A
Hypertrophic Scars
OliX Pharmaceuticals Inc
0 catalysts
Phase 2
P-12
Burns
Penicillin-binding protein
NeoMatrix Therapeutics Inc
0 catalysts
Phase 2
PH-10
Xantryl
Atopic Dermatitis (Atopic Eczema)
$PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
0 catalysts